Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma.

Li G, Zhang Z, Cai L, Tang X, Huang J, Yu L, Wang G, Zhong K, Cao Y, Liu C, Wang Y, Tong A, Zhou L
Oncoimmunology. 2021 Sep 27;10(1):1983306. doi: 10.1080/2162402X.2021.1983306. eCollection 2021. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.